Please login to the form below

Pharma Mar

This page shows the latest Pharma Mar news and features for those working in and with pharma, biotech and healthcare.

abaloparatide) and confirming its earlier rejection of Pharma Mar’s Aplidin (plitidepsin) as a treatment for multiple myeloma.

Novartis curates interactive history of medicine exhibition

Another firm active in this space is Pharma Mar, whose marine-derived antitumoral agent Yondelis (trabectedin) received US approval last month to treat unresectable or metastic liposarcoma or leiomyosarcoma. . ... Digital inspiration for pharma on mobile

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

No results were found

Add my company

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...